<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on 2 cases of long-term survivors of <z:e sem="disease" ids="C0279068" disease_type="Neoplastic Process" abbrv="">childhood solid tumors</z:e>, who developed <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> (BE) after treatment for <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> and Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, respectively </plain></SENT>
<SENT sid="1" pm="."><plain>Case 1: A stage 3 <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> was treated with surgery, <z:chebi fb="2" ids="31355">carboplatin</z:chebi>/<z:chebi fb="0" ids="4911">etoposide</z:chebi> chemotherapy, and supradiaphragmatic radiotherapy (30 Gy) </plain></SENT>
<SENT sid="2" pm="."><plain>Twelve years later, based on endoscopic and histologic findings, BE was diagnosed on the middle segment </plain></SENT>
<SENT sid="3" pm="."><plain>Case 2: A stage IIIB Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> received mechloretamine, oncovin, procarbazine, <z:chebi fb="0" ids="8382">prednisone</z:chebi>/adriamycin, <z:chebi fb="0" ids="3139">bleomycin</z:chebi>, vinblastine, <z:chebi fb="0" ids="4305">dacarbazine</z:chebi> chemotherapy and supra/subdiaphragmatic radiotherapy (25 Gy) </plain></SENT>
<SENT sid="4" pm="."><plain>Nineteen years later, BE was diagnosed associated with an <z:hpo ids='HP_0002043'>esophageal stricture</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In long-term survivors of <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">childhood tumors</z:e> who had received chest/neck radiotherapy and chemotherapy, the risk of BE may be increased, therefore the diagnosis should be considered in the presence of gastroesophageal symptoms </plain></SENT>
</text></document>